CDC37L1 divergent transcript (CDC37L1-DT)

CDC37L1 divergent transcript (CDC37L1-DT), also called CDC37L1-AS1, is an annotated long non-coding RNA (lncRNA) that overlaps or is adjacent (head-to-head orientation) to the CDC37L1 gene. The primary function of this antisense RNA is not characterized in the literature. Unlike the protein-coding gene CDC37L1—which serves as a co-chaperone involved in protein folding via interactions with HSP90 and acts as a potential tumor suppressor—there is currently no evidence that CDC37L1-DT is functionally relevant as a molecular target, nor is it associated with therapeutic intervention or clinical biomarker applications[3][1]. Consequently, CDC37L1-DT is not recognized as a primary drug target in current biomedical or therapeutic research. If structured entity recognition or drug targeting is intended, the main focus should be CDC37L1 protein, not its antisense lncRNA transcript.

Other names

CDC37L1-DTCDC37L1 divergent transcriptCDC37L1-AS1CDC37L1 antisense RNA 1 (head to head)

None (CDC37L1-DT is not pharmacologically targeted; no mechanism of action has been described)